STAT3 and ovarian carcinoma: IL-6 was also found to increase the activation of Tregs (66) and to enhance the migratory and invasive abilities of ovarian cancer cells through the JAK-STAT3 signaling pathway, involved in cancer progression, and increased EMT (67) (Figure 2C).